Abbott (Cardiometabolic) provides point-of-care testing solutions that enable clinicians to make immediate, informed treatment decisions during the patient visit. The Afinion A1c analyzer and Cholestech LDX system deliver fast, reliable results for HbA1c and lipid testing, supporting timely diagnosis and management of diabetes and cardiovascular risk. By eliminating delays associated with traditional lab testing, Abbott’s solutions help improve workflow efficiency, enhance patient engagement, and allow for real-time treatment decisions. This leads to better adherence, improved outcomes, and more effective closing of care gaps across primary care and specialty settings.